NCIt definition : IDEC-152 was developed to decrease the body's response to allergens, thereby affecting
diseases related to asthma and allergic disorders. This chimeric monoclonal antibody
binds to the CD23 receptor, by which IDEC-152 may favorably influence asthma through
its selective regulation of IgE production and its inhibition of other inflammatory
pathways.;
UNII : 8Z13S29R5A;
CAS number : 357613-86-6; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 357613-86-6
alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo
G-SRS /a ;